DrugPatentWatch Database Preview

CEFOTETAN Drug Profile

« Back to Dashboard

Which patents cover Cefotetan, and what generic alternatives are available?

Cefotetan is a drug marketed by Fresenius Kabi Usa, Hikma Farmaceutica, West-ward Pharm Corp, and B Braun. and is included in five NDAs.

The generic ingredient in CEFOTETAN is cefotetan disodium. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the cefotetan disodium profile page.

Summary for CEFOTETAN

US Patents:	0
Applicants:	4
NDAs:	5
Suppliers / Packagers:	2
Bulk Api Vendors:	40
Clinical Trials:	4
Patent Applications:	3,456
Drug Prices:	Drug price information for CEFOTETAN
DailyMed Link:	CEFOTETAN at DailyMed

Pharmacology for CEFOTETAN

Drug Class

Cephalosporin Antibacterial

Medical Subject Heading (MeSH) Categories for CEFOTETAN

Anti-Bacterial Agents

Synonyms for CEFOTETAN

(6R,7S)-4-((2-Carboxy-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-7-yl)carbamoyl)-1,3-dithietane-delta(sup 2,alpha)-malonamic acid

(6R,7S)-7-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7S)-7-(4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carboxamido)-7-methoxy-3-((1-methyl-1H-tetrazol-5-ylthio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7S)-7-(4-(carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5- yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid

(6R,7S)-7-(4-(Carbamoylcarboxymethylene)-1,3-dithiethane-2-carboxamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid

(6R,7S)-7-[[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]-oxomethyl]amino]-7-methoxy-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7S)-7-[[[4-(2-Amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid

(6R,7S)-7-[[4-(1-amino-3-hydroxy-1,3-dioxopropan-2-ylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7S)-7-[[4-(1-carbamoyl-2-hydroxy-2-oxo-ethylidene)1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7S)-7-[[4-(2-amino-1-carboxy-2-keto-ethylidene)-1,3-dithietane-2-carbonyl]amino]-8-keto-7-methoxy-3-[[(1-methyltetrazol-5-yl)thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7S)-7-[[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietane-2-carbonyl]amino]-7-methoxy-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

48SPP0PA9Q

5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha))-

69712-56-7

712C567

74356-00-6 (di-hydrochloride salt)

7beta-({[4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl}amino)-7alpha-methoxy-3-{[(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl}-3,4-didehydrocepham-4-carboxylic acid

A-8477

AB00513847

AC-2141

AC1L1E33

AKOS015896100

Apacef

BCP10745

BDBM80643

BPBio1_000668

BRN 1208088

BSPBio_000606

C-23677

C06886

C17H17N7O8S4

CAS-69712-56-7

CC-25578

CCG-220473

Cefotetan (JP17/USP/INN)

Cefotetan [USAN:USP:INN:BAN]

Cefotetan free acid

Cefotetan, 95-103%

Cefotetan, Antibiotic for Culture Media Use Only

Cefotetanum

Cefotetanum [INN-Latin]

CHEBI:3499

CHEMBL474579

cid_53025

D00260

DB01330

DSSTox_CID_2762

DSSTox_GSID_22762

DSSTox_RID_76720

DTXSID1022762

EINECS 274-093-3

FT-0603035

HMS1569O08

HMS2096O08

HMS2234C15

HMS3713O08

I06-1743

ICI 156,834

ICI 156834

ICI-156834

KB-277446

MLS002153829

MolPort-005-935-573

NCGC00016914-01

NCGC00179507-01

Prestwick0_000473

Prestwick1_000473

Prestwick2_000473

Prestwick3_000473

SCHEMBL61376

SMR001233197

SPBio_002545

SR-01000842155

SR-01000842155-3

Tox21_110681

UNII-48SPP0PA9Q

W-104601

ZINC3830441

ZX-AFC002959

US Patents and Regulatory Information for CEFOTETAN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fresenius Kabi Usa	CEFOTETAN	cefotetan disodium	INJECTABLE;INJECTION	065374-001	Aug 9, 2007	AP	RX	No	Yes
B Braun	CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER	cefotetan disodium	INJECTABLE;INJECTION	065430-001	Aug 9, 2007		RX	Yes	Yes
Hikma Farmaceutica	CEFOTETAN	cefotetan disodium	INJECTABLE;INJECTION	091031-001	Oct 26, 2011	AP	RX	No	No
B Braun	CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER	cefotetan disodium	INJECTABLE;INJECTION	065430-002	Aug 9, 2007		RX	Yes	Yes
Fresenius Kabi Usa	CEFOTETAN	cefotetan disodium	INJECTABLE;INJECTION	065374-002	Aug 9, 2007	AP	RX	No	Yes
Fresenius Kabi Usa	CEFOTETAN	cefotetan disodium	INJECTABLE;INJECTION	065375-001	Aug 9, 2007	AP	RX	No	Yes